Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Glucosamine on Intraocular Pressure in Rheumatoid Arthritis
NCT02306083Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Placebo with Glucosamine Sulfate (2 arms). Primary endpoint: Intraocular pressure changes at 6 months. Status: unknown.
02
Drugs
glucosamine sulphate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02306083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306083.